Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. BDB752175

CD45RB Mouse, anti-Human, R718, Clone: MT4 (6B6), BD OptiBuild™

Catalog No. BDB752175 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
50 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB752175 50 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. BDB752175 Supplier BD Biosciences Supplier No. 752175
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

MT4 (6B6) reacts with the 190, 205 and 220 kDa isoforms of the glycoprotein cell-surface antigen, CD45RB. The antigen is expressed primarily on a subset of human B and T lymphocytes, monocytes, macrophages and granulocytes (weak). CD4+, CD45RA- (memory T cells) cells show a differential expression of CD45RB. Bright CD45RB expression correlates with higher proliferation and IFNγ production when compared with dim CD45RB expression. CD45RB expression may be a mechanism for fine-tuning the responsiveness of memory cells in vivo.

TRUSTED_SUSTAINABILITY

Specifications

Antigen CD45RB
Applications Flow Cytometry
Classification Monoclonal
Clone MT4 (6B6)
Conjugate R718
Host Species Mouse
Quantity 50 μg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human
Content And Storage Refrigerate Upon Arrival
Form Liquid
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.